https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
3%. Elderly patients and those with diabetes had lower objective olfactory evaluation results than young and non-diabetic individuals. The prevalence of SLS in severe COVID-19 patients appears to be lower than previously estimated in mild-to-moderate COVID-19 forms. Future comparative studies are needed to explore the predictive value of SLS for COVID-19 severity. The prevalence of SLS in severe COVID-19 patients appears to be lower than previously estimated in mild-to-moderate COVID-19 forms. Future comparative studie
Like
Comment
Share
